Showing results (1-10 of 348) with videos related to
Sort By:
Pageof 35
Current Drug Discovery Technologies|May 23, 2006
Development and validation of an in silico P450 profiler based on pharmacophore modelsDaniela Schuster, Christian Laggner, Theodora M Steindl, et al.Journal of Chemical Information and Modeling|September 26, 2006
Parallel screening: a novel concept in pharmacophore modeling and virtual screeningTheodora M Steindl, Daniela Schuster, Christian Laggner, et al.Journal of Computer-Aided Molecular Design|September 30, 2006
High-throughput structure-based pharmacophore modelling as a basis for successful parallel virtual screeningTheodora M Steindl, Daniela Schuster, Gerhard Wolber, et al.Journal of Chemical Information and Modeling|May 23, 2006
Pharmacophore modeling and in silico screening for new P450 19 (aromatase) inhibitorsDaniela Schuster, Christian Laggner, Theodora M Steindl, et al.Journal of Chemical Information and Modeling|March 27, 2007
Parallel screening and activity profiling with HIV protease inhibitor pharmacophore modelsTheodora M Steindl, Daniela Schuster, Christian Laggner, et al.Current Topics in Medicinal Chemistry|August 22, 2006
Predicting drug metabolism induction in silicoDaniela Schuster, Theodora M Steindl, Thierry LangerJournal of Computer-Aided Molecular Design|October 26, 2007
Pharmacophore modeling and parallel screening for PPAR ligandsPatrick Markt, Daniela Schuster, Johannes Kirchmair, et al.Biochemical Pharmacology|December 17, 2009
The UV-filter benzophenone-1 inhibits 17beta-hydroxysteroid dehydrogenase type 3: Virtual screening as a strategy to identify potential endocrine disrupting chemicalsLyubomir G Nashev, Daniela Schuster, Christian Laggner, et al.Journal of Medicinal Chemistry|June 7, 2008
Discovery of nonsteroidal 17beta-hydroxysteroid dehydrogenase 1 inhibitors by pharmacophore-based screening of virtual compound librariesDaniela Schuster, Lyubomir G Nashev, Johannes Kirchmair, et al.Journal of Medicinal Chemistry|June 9, 2006
The discovery of new 11beta-hydroxysteroid dehydrogenase type 1 inhibitors by common feature pharmacophore modeling and virtual screeningDaniela Schuster, Evelyne M Maurer, Christian Laggner, et al.Pageof 35